Literature DB >> 19509481

High rate of misclassification of treatment failure based on WHO immunological criteria.

Barbara Castelnuovo, Agnes Kiragga, Petra Schaefer, Andrew Kambugu, Yukari Manabe.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19509481     DOI： 10.1097/QAD.0b013e32832cbd43

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa.

Authors:  Michael Abouyannis; Joris Menten; Agnes Kiragga; Lutgarde Lynen; Gavin Robertson; Barbara Castelnuovo; Yukari C Manabe; Steven J Reynolds; Lesley Roberts
Journal:  AIDS       Date:  2011-08-24       Impact factor: 4.177

2.  Regional differences in predictive accuracy of WHO immunologic failure criteria.

Authors:  Agnes N Kiragga; Barbara Castelnuovo; Moses R Kamya; Richard Moore; Yukari C Manabe
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

3.  Is CD4 monitoring needed among ugandan clients achieving a virologic and immunologic response to treatment?

Authors:  Steven J Reynolds; Joseph B Sempa; Agnes N Kiragga; Kevin Newell; Gertrude Nakigozi; Ronald Galiwango; Ron Gray; Thomas C Quinn; David Serwadda; Larry Chang
Journal:  AIDS Patient Care STDS       Date:  2014-10-07       Impact factor: 5.078

4.  Practices to improve identification of adult antiretroviral therapy failure at the Lighthouse Trust clinic in Lilongwe, Malawi.

Authors:  Charles K Vorkas; Hannock Tweya; Dalitso Mzinganjira; George Dickie; Ralf Weigel; Sam Phiri; Mina C Hosseinipour
Journal:  Trop Med Int Health       Date:  2011-11-01       Impact factor: 2.622

5.  Optimal Allocation of Gold Standard Testing under Constrained Availability: Application to Assessment of HIV Treatment Failure.

Authors:  Tao Liu; Joseph W Hogan; Lisa Wang; Shangxuan Zhang; Rami Kantor
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

6.  Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Authors:  Sabine M Hermans; Agnes N Kiragga; Petra Schaefer; Andrew Kambugu; Andy I M Hoepelman; Yukari C Manabe
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

7.  Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda.

Authors:  Steven J Reynolds; Hakim Sendagire; Kevin Newell; Barbara Castelnuovo; Immaculate Nankya; Moses Kamya; Thomas C Quinn; Yukari C Manabe; Andrew Kambugu
Journal:  BMC Infect Dis       Date:  2012-12-27       Impact factor: 3.090

8.  Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings.

Authors:  Barbara Castelnuovo; Joseph Sempa; Kiragga N Agnes; Moses R Kamya; Yukari C Manabe
Journal:  AIDS Res Treat       Date:  2011-04-10

9.  Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.

Authors:  Alain M Vandormael; David R Boulware; Frank C Tanser; Till W Bärnighausen; Katharine E Stott; Tulio de Oliveira
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

10.  Reasons for first line ART modification over the years during the ART scale up in Uganda.

Authors:  B Castelnuovo; F Mubiru; I Kalule; A Kiragga
Journal:  AIDS Res Ther       Date:  2019-10-09       Impact factor: 2.250
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.